Kay Macleod, Ph.D., Professor, The Ben May Department for Cancer Research, University of Chicago, Chicago, IL - emailĪndrea McClatchey, Ph.D., Professor, MGH Cancer Center, Harvard Medical School Department of Pathology, Charlestown, MA - emailĭavid G. Scott Lowe, Ph.D., Member, Memorial Sloan Kettering Cancer Center, Chair of the Cancer Biology and Genetics Program and Howard Hughes Medical Institute Investigator, New York, NY - email Leanne Li, M.D.-Ph.D., Group Leader, Cancer-Neuroscience Laboratory, The Francis Crick Institute, London, UK - email Lindsay LaFave, Ph.D., Assistant Professor, Albert Einsten College of Medicine and Albert Einstein Cancer Center, New York, NY - email Lee Moffitt Cancer Center & Research Institute, Tampa, FL - email Joe Kissil, Ph.D., Chair, Dept of Molecular Oncology Co-leader of the Cancer Biology & Evolution Program, H. JungHo Kim, Ph.D., Professor, Dept of Life Science, Sogang University, Seoul, Korea - emailĭavid Kirsch, M.D.-Ph.D., Professor and Vice Chair for Basic and Translational Research, Department of Radiation Oncology, Duke University Medical Center, Durham, NC - email Nikhil Joshi, Ph.D, Associate Professor, Dept of Immunobiology, Yale University, New Haven, CT - emailĬarla Bender Kim, Ph.D, Professor, Dept of Genetics, Children's Hospital Stem Cell Program/Harvard Stem Cell Institute, Harvard Medical School, Boston, MA - email William Hwang, MD,-Ph.D, Assistant Professor, Center for Systems Biology, Harvard Medical School/Masschusetts General Hospital, Boston, MA - emailĪlex Jaeger, Ph.D, Assistant Member, Molecular Oncology Department, Moffitt Cancer Center, Tampa, FL - emailĬhengcheng Jin, Ph.D., Assistant Professor, Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA - email Sunil Hingorani, MD,-Ph.D, Member, Fred Hutchinson Cancer Research Center, Seattle, WA - email Kevin Haigis, Ph.D., Chief Research Officer, Dana-Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School, Boston, MA - email Vasilena (Leny) Gocheva, Ph.D., Associate Director of Program Management, Break Through Cancer, Cambridge, MA - email Sharon Friedlander, Ph.D., Associate Director, Reverse Translational Development Lead, Takeda Oncology, Cambridge, MA - email William Freed-Pastor, M.D.-Ph.D., Assistant Professor, Dana Farber Cancer Institute/Harvard Medical School, Boston, MA - email Nadya Dimitrova, Ph.D., Assistant Professor, Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT - emailĭaniela Dinulescu, Ph.D., Associate Professor, Director of GYN Oncology Research Division at Brigham and Women's Hospital, Harvard Medical School, Boston, MA - emailīanu Eskiocak, Ph.D., Principle Scientist, Prizer, San Diego, CA - emailĪnna Farago, M.D.-Ph.D., Senior Clinical Program Leader, Novartis Institutes for Biomedical Research, Cambridge, MA - emailĭavid Feldser, Ph.D., Associate Professor, Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA - emailĮlsa Flores, Ph.D., Associate Center Director of Basic Sciences, H. Genevieve Crane (née Kruger), M.D.-Ph.D., Staff Hematopathologist, Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH - emailĪnnemieke de Vries, Ph.D., Chief Science and Technology Officer, Netherlands Forensic Institute, The Hague, The Netherlands - email Karen Cichowski, Ph.D., Professor, Divison of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA - emailĬarla Concepcion, Ph.D., Assistant Professor, Department of Molecular Pharmacology & Therapeutics, Columbia University, New York, NY - email Megan Burger, Ph.D., Assistant Professor, Departments of Cell, Developmental and Cancer Biology, Oregon Health Sciences University, Portland, OR - email Laura Attardi, Ph.D., Professor, Departments of Radiation Oncology and Genetics, Stanford University School of Medicine, Stanford, CA - email
0 Comments
Leave a Reply. |